Source: Journal of Bioequivalence & Bioavailability. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
MENDES, Gustavo Duarte et al. The use of healthy volunteers to evaluate bioequivalence of antineoplasic drugs: pilot studies with capecitabine. Journal of Bioequivalence & Bioavailability, v. S1, p. 1-8, 2011Tradução . . Disponível em: https://doi.org/10.4172/jbb.S1-005. Acesso em: 03 nov. 2024.APA
Mendes, G. D., Babadopulos, T., Chen, L. S., Ilha, J. O., Magalhães, J. C. de A., Alkharfy, K., & De Nucci, G. (2011). The use of healthy volunteers to evaluate bioequivalence of antineoplasic drugs: pilot studies with capecitabine. Journal of Bioequivalence & Bioavailability, S1, 1-8. doi:10.4172/jbb.S1-005NLM
Mendes GD, Babadopulos T, Chen LS, Ilha JO, Magalhães JC de A, Alkharfy K, De Nucci G. The use of healthy volunteers to evaluate bioequivalence of antineoplasic drugs: pilot studies with capecitabine [Internet]. Journal of Bioequivalence & Bioavailability. 2011 ; S1 1-8.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4172/jbb.S1-005Vancouver
Mendes GD, Babadopulos T, Chen LS, Ilha JO, Magalhães JC de A, Alkharfy K, De Nucci G. The use of healthy volunteers to evaluate bioequivalence of antineoplasic drugs: pilot studies with capecitabine [Internet]. Journal of Bioequivalence & Bioavailability. 2011 ; S1 1-8.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4172/jbb.S1-005